Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 11(1): 21671, 2021 11 04.
Article in English | MEDLINE | ID: mdl-34737385

ABSTRACT

Trypanosoma cruzi-the causative agent of Chagas disease-like other kinetoplastids, relies mostly on post-transcriptional mechanisms for regulation of gene expression. However, trypanosomatids undergo drastic changes in nuclear architecture and chromatin structure along their complex life cycle which, combined with a remarkable set of reversible histone post-translational modifications, indicate that chromatin is also a target for control of gene expression and differentiation signals in these organisms. Chromatin-modifying enzymes have a direct impact on gene expression programs and DNA metabolism. In this work, we have investigated the function of T. cruzi histone deacetylase 4 (TcHDAC4). We show that, although TcHDAC4 is not essential for viability, metacyclic trypomastigote TcHDAC4 null mutants show a thin cell body and a round and less condensed nucleus located very close to the kinetoplast. Sixty-four acetylation sites were quantitatively evaluated, which revealed H2AT85ac, H4K10ac and H4K78ac as potential target sites of TcHDAC4. Gene expression analyses identified three chromosomes with overrepresented regions of differentially expressed genes in the TcHDAC4 knockout mutant compared with the wild type, showing clusters of either up or downregulated genes. The adjacent chromosomal location of some of these genes indicates that TcHDAC4 participates in gene expression regulation during T. cruzi differentiation.


Subject(s)
Gene Expression Regulation/genetics , Histone Deacetylases/deficiency , Histone Deacetylases/genetics , Trypanosoma cruzi/genetics , Acetylation , Animals , Cell Culture Techniques , Chagas Disease/genetics , Chlorocebus aethiops , Chromatin/metabolism , Gene Expression/genetics , Humans , Life Cycle Stages/genetics , Protein Processing, Post-Translational/genetics , Protozoan Proteins/genetics , Repressor Proteins/deficiency , Repressor Proteins/genetics , Trypanosoma cruzi/metabolism , Vero Cells
2.
J Cell Biol ; 195(7): 1141-57, 2011 Dec 26.
Article in English | MEDLINE | ID: mdl-22201125

ABSTRACT

Mammalian Smaug1/Samd4A is a translational repressor. Here we show that Smaug1 forms mRNA-silencing foci located at postsynapses of hippocampal neurons. These structures, which we have named S-foci, are distinct from P-bodies, stress granules, or other neuronal RNA granules hitherto described, and are the first described mRNA-silencing foci specific to neurons. RNA binding was not required for aggregation, which indicates that S-foci formation is not a consequence of mRNA silencing. N-methyl-D-aspartic acid (NMDA) receptor stimulation provoked a rapid and reversible disassembly of S-foci, transiently releasing transcripts (the CaMKIIα mRNA among others) to allow their translation. Simultaneously, NMDA triggered global translational silencing, which suggests the specific activation of Smaug1-repressed transcripts. Smaug1 is expressed during synaptogenesis, and Smaug1 knockdown affected the number and size of synapses, and also provoked an impaired response to repetitive depolarizing stimuli, as indicated by a reduced induction of Arc/Arg3.1. Our results suggest that S-foci control local translation, specifically responding to NMDA receptor stimulation and affecting synaptic plasticity.


Subject(s)
Gene Silencing/drug effects , N-Methylaspartate/pharmacology , RNA, Messenger/genetics , Repressor Proteins/genetics , Synapses/drug effects , Synapses/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Cell Line, Tumor , Cells, Cultured , Dendrites/metabolism , HeLa Cells , Hippocampus/cytology , Hippocampus/drug effects , Hippocampus/metabolism , Humans , Neurons/cytology , Neurons/drug effects , Neurons/metabolism , Polyribosomes/metabolism , Protein Biosynthesis , RNA, Messenger/metabolism , Receptors, N-Methyl-D-Aspartate/agonists , Receptors, N-Methyl-D-Aspartate/metabolism , Repressor Proteins/deficiency , Repressor Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL